Literature DB >> 32603411

Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?

Paul S Gaynon1,2, Etan Orgel1,2, Lingyun Ji2,3.   

Abstract

Entities:  

Year:  2020        PMID： 32603411     DOI： 10.1182/blood.2020005258

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Therapy-induced mutagenesis in relapsed ALL is supported by mutational signature analysis.

Authors:  Samuel W Brady; Xiaotu Ma; Bin-Bing S Zhou; Ching-Hon Pui; Jun J Yang; Jinghui Zhang
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

Review 2.  Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Authors:  Eulàlia Genescà; Celia González-Gil
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.